Counterpoint: Alternative trial designs for antifungal drugs - Time to talk

被引：7
作者：
Powers, JH
机构：
[1] US FDA, Div Special Pathogen & Immunol Drug Prod, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
[2] NIAID, NIH, Bethesda, MD 20892 USA
来源：
CLINICAL INFECTIOUS DISEASES | 2001年 / 33卷 / 01期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1086/320895
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：107 / 109
页数：3
相关论文
共 6 条
[1]   A comparison of observational studies and randomized, controlled trials. [J].
Benson, K ;
Hartz, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (25) :1878-1886
[2]   An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome [J].
Denning, DW ;
Marinus, A ;
Cohen, J ;
Spence, D ;
Herbrecht, R ;
Pagano, L ;
Kibbler, C ;
Kcrmery, V ;
Offner, F ;
Cordonnier, C ;
Jehn, U ;
Ellis, M ;
Collette, L ;
Sylvester, R .
JOURNAL OF INFECTION, 1998, 37 (02) :173-180
[3]   Aspergillosis case - Fatality rate: Systematic review of the literature [J].
Lin, SJ ;
Schranz, J ;
Teutsch, SM .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) :358-366
[4]   Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses [J].
Rex, JH ;
Walsh, TJ ;
Nettleman, M ;
Anaissie, EJ ;
Bennett, JE ;
Bow, EJ ;
Carillo-Munoz, AJ ;
Chavanet, P ;
Cloud, GA ;
Denning, DW ;
de Pauw, BE ;
Edwards, JE ;
Hiemenz, JW ;
Kauffman, CA ;
Lopez-Berestein, G ;
Martino, P ;
Sobel, JD ;
Stevens, DA ;
Sylvester, R ;
Tollemar, J ;
Viscoli, C ;
Viviani, MA ;
Wu, T .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (01) :95-106
[5]   RANDOMIZED VERSUS HISTORICAL CONTROLS FOR CLINICAL-TRIALS [J].
SACKS, H ;
CHALMERS, TC ;
SMITH, H .
AMERICAN JOURNAL OF MEDICINE, 1982, 72 (02) :233-240
[6]  
*US FDA, 2001, 21227 NDA US FOOD DR
1